These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
312 related items for PubMed ID: 32914197
21. Development of a Multiparametric Renal CT Algorithm for Diagnosis of Clear Cell Renal Cell Carcinoma Among Small (≤ 4 cm) Solid Renal Masses. Al Nasibi K, Pickovsky JS, Eldehimi F, Flood TA, Lavallee LT, Tsampalieros AK, Schieda N. AJR Am J Roentgenol; 2022 Nov; 219(5):814-823. PubMed ID: 35766532 [Abstract] [Full Text] [Related]
22. Pretreatment differentiation of renal cell carcinoma subtypes by CT: the influence of different tumor enhancement measurement approaches. Zokalj I, Marotti M, Kolarić B. Int Urol Nephrol; 2014 Jun; 46(6):1089-100. PubMed ID: 24381132 [Abstract] [Full Text] [Related]
25. Differentiation of renal cell carcinoma subtypes with different iodine quantification methods using single-phase contrast-enhanced dual-energy CT: areal vs. volumetric analyses. Dai C, Cao Y, Jia Y, Ding Y, Sheng R, Zeng M, Zhou J. Abdom Radiol (NY); 2018 Mar; 43(3):672-678. PubMed ID: 28721478 [Abstract] [Full Text] [Related]
26. Automated classification of solid renal masses on contrast-enhanced computed tomography images using convolutional neural network with decision fusion. Zabihollahy F, Schieda N, Krishna S, Ukwatta E. Eur Radiol; 2020 Sep; 30(9):5183-5190. PubMed ID: 32350661 [Abstract] [Full Text] [Related]
27. Differentiation of Predominantly Solid Enhancing Lipid-Poor Renal Cell Masses by Use of Contrast-Enhanced CT: Evaluating the Role of Texture in Tumor Subtyping. Varghese BA, Chen F, Hwang DH, Cen SY, Desai B, Gill IS, Duddalwar VA. AJR Am J Roentgenol; 2018 Dec; 211(6):W288-W296. PubMed ID: 30240299 [Abstract] [Full Text] [Related]
28. Diagnosis of Sarcomatoid Renal Cell Carcinoma With CT: Evaluation by Qualitative Imaging Features and Texture Analysis. Schieda N, Thornhill RE, Al-Subhi M, McInnes MD, Shabana WM, van der Pol CB, Flood TA. AJR Am J Roentgenol; 2015 May; 204(5):1013-23. PubMed ID: 25905936 [Abstract] [Full Text] [Related]
32. Differentiation of Clear Cell Renal Cell Carcinoma from other Renal Cell Carcinoma Subtypes and Benign Oncocytoma Using Quantitative MDCT Enhancement Parameters. Moldovanu CG, Petresc B, Lebovici A, Tamas-Szora A, Suciu M, Crisan N, Medan P, Buruian MM. Medicina (Kaunas); 2020 Oct 28; 56(11):. PubMed ID: 33126571 [Abstract] [Full Text] [Related]
33. Comparison of Contrast-Enhanced Multiphase Renal Protocol CT Versus MRI for Diagnosis of Papillary Renal Cell Carcinoma. Dilauro M, Quon M, McInnes MD, Vakili M, Chung A, Flood TA, Schieda N. AJR Am J Roentgenol; 2016 Feb 28; 206(2):319-25. PubMed ID: 26797358 [Abstract] [Full Text] [Related]
34. Utility of the Aortic-Lesion-Attenuation-Difference (ALAD) and Peak Early-Phase Enhancement Ratio (PEER) to differentiate benign from malignant renal masses. Kahn AE, Lomax SJ, Bajalia EM, Ball CT, Thiel DD. Can J Urol; 2020 Aug 28; 27(4):10278-10284. PubMed ID: 32861252 [Abstract] [Full Text] [Related]
36. Accuracy of multiphase helical tomography in detection and characterisation of suspected renal masses using histopathological findings as gold standard. Siddiqui TS, Tariq A, Rehman B, Siddiqui TS, Asim A. J Ayub Med Coll Abbottabad; 2010 Aug 28; 22(3):170-3. PubMed ID: 22338448 [Abstract] [Full Text] [Related]